Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Deborah Schmiel"'
Autor:
Nishant Mohan, Atul Agrawal, Yi Shen, Katie L. Winarski, Yukinori Endo, Milos Dokmanovic, Deborah Schmiel, Jiwen Zheng, David S. Rotstein, Lorraine C. Pelosof, Wen Jin Wu
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1381 (2022)
We generated two IgG1-like bispecific antibodies (BsAbs) with different molecular formats, symmetrical DVD-Ig and asymmetrical knob-in-hole (KIH), targeting the same antigens, EGFR and PD-L1 (designated as anti-EGFR/PD-L1). We performed the physioche
Externí odkaz:
https://doaj.org/article/58be08b2889c41238320db318c0f3eb4
Autor:
Richard Pazdur, Ann T. Farrell, Qing Zhou, Ping Zhao, Pengfei Song, Deborah Schmiel, Tiffany K. Ricks, Nitin Mehrotra, Susan Kirshner, Robert C. Kane, Candace Gomez-Broughton, Brenda J. Gehrke, Haw-Jyh Chiu, Reyes Candau-Chacon, Carolyn L. Yancey, Albert Deisseroth, Chia-Wen Ko, Donna Przepiorka
Preferred Terms included in grouped terms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04eb5dd9d2864438c9fd3c493117694a
https://doi.org/10.1158/1078-0432.22457625.v1
https://doi.org/10.1158/1078-0432.22457625.v1
Autor:
Mark Paciga, Emmanuel Sampene, Jingyu Yu, Patricia Keegan, Rashmi Rawat, Hong Zhao, Jennie T. Chang, Hongshan Li, Deborah Schmiel, Runyan Jin, Richard Pazdur, Whitney S. Helms, Marc R. Theoret, Kun He, Shawna L. Weis, Meredith K. Chuk, Liang Zhao
Publikováno v:
Clinical Cancer Research. 23:5666-5670
On September 4, 2014, the FDA approved pembrolizumab (KEYTRUDA; Merck Sharp & Dohme Corp.) with a recommended dose of 2 mg/kg every 3 weeks by intravenous infusion for the treatment of patients with unresectable or metastatic melanoma who have progre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba6ff85f01dfec65ef77be9fcc96883
https://doi.org/10.1158/1078-0432.ccr-16-0663
https://doi.org/10.1158/1078-0432.ccr-16-0663
Autor:
Nitin Mehrotra, Ping Zhao, Tiffany K. Ricks, Candace Gomez-Broughton, Carolyn L. Yancey, Donna Przepiorka, Chia-Wen Ko, Pengfei Song, Robert C. Kane, Richard Pazdur, Deborah Schmiel, Albert Deisseroth, Qing Zhou, Brenda J. Gehrke, Ann T. Farrell, Susan L. Kirshner, Reyes Candau-Chacon, Haw-Jyh Chiu
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 21(18)
On December 3, 2014, the FDA granted accelerated approval of blinatumomab (Blincyto; Amgen, Inc.) for treatment of Philadelphia chromosome–negative relapsed or refractory precursor B-cell acute lymphoblastic leukemia (R/R ALL). Blinatumomab is a re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0422e1e4aacff33cf972ba96a7696d8c
https://pubmed.ncbi.nlm.nih.gov/26374073
https://pubmed.ncbi.nlm.nih.gov/26374073
Publikováno v:
Biotechnology and Bioengineering. 42:1293-1300
A series of Bombyx mori nuclear polyhedrosis virus (Bm-NPV) transfer vectors has been developed containing various lengths of the polyhedrin promoter, including sequences 3' of the initiation codon. The ATG initiation codon was mutated in some of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dda54a282b74b98cadfba2457037cb7e
https://doi.org/10.1002/bit.260421106
https://doi.org/10.1002/bit.260421106